Loading clinical trials...
Loading clinical trials...
Waldenström's macroglobulinaemia (WM) is a lymphoproliferative disorder characterized by a monoclonal IgM paraprotein and morphological evidence of lymphoplasmacytic lymphoma: the cells are IgM+, IgD+...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
French Study Group on Chronic Lymphoid Leukemia
Collaborators
NCT05294731 · B-cell Malignancy, Non-Hodgkin Lymphoma, and more
NCT07387471 · Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma
NCT05006716 · B-cell Malignancy, Marginal Zone Lymphoma, and more
NCT04195633 · Acute Leukemia, Acute Lymphoblastic Leukemia, and more
NCT07231952 · Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma
Hôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions